MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Myoclonus: Clinical features"

  • 2025 International Congress

    A Rare Case of Anti-Hu Opsoclonus-Myoclonus Syndrome after Immune Checkpoint Inhibitor Immunotherapy in a Patient with Small Cell Lung Cancer in Remission

    L. Hong, P. Atit, R. Patil, E. Sandberg, A. Makarova (Tampa, USA)

    Objective: To describe a case of anti-Hu/ANNA-1 Opsoclonus-Myoclonus syndrome (OMS) in a patient with small cell lung cancer (SCLC) after treatment with an immune checkpoint…
  • 2025 International Congress

    Uncommon Presentation of Moyamoya Disease (MMD): A Case of Negative Myoclonus

    S. Park (Daejeon, Republic of Korea)

    Objective: We describe a case of MMD in which the patient presented with negative myoclonus. Background: Moyamoya disease (MMD) is a progressive cerebrovascular disorder characterized…
  • 2025 International Congress

    Focal Lower Limb Myoclonus Heralding Adult Onset Fulminant SSPE

    S. Jha, S. Pendyala (Kolkata, India)

    Objective: We report a case adult onset fulminant SSPE with focal lower limb myoclonus as the predominant presenting movement disorder. Background: Myoclonus remains a defining…
  • 2025 International Congress

    A Standardised, Semi-automated Computational Approach to the Analysis of Electrophysiology in Orthostatic Myoclonus

    N. Jeyakumar, S. Nagaratnam, G. Jeyakumar, P. Becker, F. Chang, V. Fung (Westmead, Australia)

    Objective: We sought to develop a standardised, computationally tractable approach to the analysis of electrophysiology in orthostatic myoclonus by developing novel definition criteria for myoclonic…
  • 2025 International Congress

    Insights into Myoclonus Dystonia from an Indian movement disorder clinic

    F. Mustafa, A. Mudda, A. Agarwal, A. Srivastava, D. Garg, A. Garg (New Delhi, India)

    Objective: To describe the clinical profile, etiology and treatment profile of myoclonus dystonia patients attending a single movement disorder clinic. Background: Myoclonus-dystonia (MD) is a…
  • 2025 International Congress

    Deciphering differences in Functional Movement Disorders between Children and Adults

    D. Kalikavil Puthanveedu, A. Cherian (Thiruvananthapuram, India)

    Objective: To compare the characteristics of FMDs in children and adults Background: Functional movement disorders (FMDs) exhibit notable differences in phenomenology and treatment responses between…
  • 2025 International Congress

    Rare Phenomenology with Nicotinic Ganglionic Acetylcholine Receptor Antibodies

    V. Melnic, J. Frey (Morgantown, USA)

    Objective: Autoimmune dysautonomia has been described in patients with positive nicotinic ganglionic (alpha-3) acetylcholine receptor antibodies (α3-AchR Ab). We present a case of myoclonus in…
  • 2025 International Congress

    Autoimmune GFAP astrocytopathy as an Etiology of Opsoclonus-Myoclonus-Ataxia Syndrome

    T. Thammongkolchai, P. Termsarasab (Bangkok, Thailand)

    Objective: To report a case of opsoclonus-myoclonus-ataxia syndrome (OMAS) due to autoimmune GFAP astrocytopathy. Background: OMAS is associated with brainstem pathology. In adults, common causes…
  • 2025 International Congress

    Expanding the Clinical Spectrum of Fejerman Syndrome: Insights from Video EEG and Long-Term Follow-Up

    M. Hull, M. Sudheendra, M. Gonzalez, B. Evans, D. Takacs, A. Katyayan (Houston, USA)

    Objective: We review the clinical spectrum of infants diagnosed with Fejerman syndrome, provide detailed phenomenology through video review and long-term outcomes Background: First described by…
  • 2025 International Congress

    Genetic and clinical spectrum of pediatric hyperkinetic movement disorders in a Spanish tertiary center

    JD. Ortigoza Escobar, B. Antomil Guerrero, L. Marti-Sanchez, D. Yubero, C. Xiol Viñas, A. Alcalá Sanmartín, C. Hernando Davalillo, J. Armstrong, L. Martorell (Barcelona, Spain)

    Objective: To investigate the genetic etiology of pediatric hyperkinetic movement disorders (PMDs), characterize their associated phenotypes, comorbidities, and neuroimaging findings, and evaluate the impact of…
  • 1
  • 2
  • 3
  • …
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #29077 (not found)
  • #29056 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28189 (not found)
  • Welcome to the MDS Abstracts Site
  • Advanced Search
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley